Bioconjugation Market to Hit USD 10.86 Billion by 2029 with 15.6% CAGR | MarketsandMarkets™

Barchart · 10/17 09:01

DELRAY BEACH, Fla., Oct. 17, 2024 /PRNewswire/ -- The global bioconjugation market is expected to grow to USD 10.86 billion by 2029, up from USD 5.27 billion in 2024, at a CAGR of 15.6% over the forecast period. The market for bioconjugation is expanding due to factors such as the advancement of bioconjugation technology and the rise in the approval of bioconjugate drugs. The market for bioconjugation is also growing owing to the increasing use of targeted therapies, mainly in oncology applications, and the ongoing growth of the field in diagnostics and drug delivery applications. Advances in technologies of bioconjugation, such as site-specific conjugation and click chemistry, have improved the accuracy and efficiency of products of bioconjugation, Therefore, they are increasingly being integrated into pharmaceutical and biotechnology companies.

Read more at prnewswire.com